Skip to content

Side by side

Ipamorelin vs PT-141

Both are discussed for muscle & performance. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.

Ipamorelin and PT-141 compared on what BioAlmanac records.
 IpamorelinPT-141
What it isA selective growth hormone secretagogue that prompts a short pulse of GH release. Widely used, and supported almost entirely by early pharmacology rather than outcome trials.A melanocortin receptor agonist approved by the FDA for low sexual desire in premenopausal women. It acts on the brain rather than on blood flow.
EvidenceHow much human evidence exists, not how well it works.Early human trialsApproved for another indication
Regulatory statusReviewed 2026-08-12Not approved for human use in the United States for any indication. The FDA has identified ipamorelin as a substance raising concerns for use in compounded preparations. Material sold online is a research chemical.Approved by the FDA as a prescription medicine for hypoactive sexual desire disorder in premenopausal women. It is not approved for use in men, and material sold as a research chemical is not the approved product.
RoutesSubcutaneousSubcutaneous, Nasal
Half-life2 hours2.7 hours
Cheapest per mgVials only, read from vendors' own listings and dated on the price index.$2.00/mg$1.88/mg
Median per mg$5.50/mg$4.00/mg
Vendors with a price5449
Storage once mixedRefrigerated at 2–8 °C. Do not freeze once mixed.Refrigerated at 2–8 °C. Do not freeze once mixed.

Compare two other compounds · The full price index

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.